Detection of frameshift mutations of the transforming growth factor β receptor II in gastric cancers with microsatellite instability
Tóm tắt
OBJECTIVE To study the relationship among microsatellite instability (MSI), frameshift mutations (FM) of the transforming growth factor β receptor II (TGFβR II), methylation state of the hMLH1 promoter and hMLH1 protein expression level in gastric cancers, and to explore their relationship to gastric carcinogenesis. METHODS DNA was isolated from 101 gastric specimens and 5 microsatellite loci were detected. PCR, electrophoresis on denatured polyacrylamide gels and silver staining were performed to detect the MSI. The FMs of TGFβR II were also screened with the same method. HMLH1 methylation was analyzed by methylation specific PCR (MSP) and sequencing. HMLH1 protein expression was detected using immunohisto-chemistry. RESULTS The incidence of MSIs was 53.7% and 0% in the cancers and normal tissues, respectively, with the frequency of MSIs being significantly higher in the gastric cancers compared to the normal gastric tissues (P<0.05). The frequency of hMLH1 methylation was 41.5%(17/41) in the gastric cancers and 0% (0/60) in the normal group. Decreased hMLH1 expression was observed in 94.1%(16/17) of cases exhibiting methylation. FMs of TGFβR II were identified in 5 (62.5%) of the 8 samples with MSI-H. In contrast, FMs were not found in MSI-L or microsatellite stable (MSS) cases. CONCLUSION MSIs and FMs of TGFβR II may play an important role in gastric carcinogenesis. HMLH1 methylation is an important modification of the DNA which results in inactivation of hMLH1 and mismatch repair defects which lead to MSIs and FMs of TGFβR II.
Tài liệu tham khảo
Wang D, Xu Y, Geng X. Relationship between epithelial cadherin expression level and gastric cancer matastasis. Journal of Tianjin Medical University (Chinese). 2005;4:531–534.
Halling KC, Harper J, Moskaluk CA, et al. Origin of microsatellite instability in gastric cancer. Am J Pathol. 1999;155:205–211.
Bruckheimer EM, Kyprianou N. Dihydrotestosterone enhances transforming growth factor-β induced apoptosis in hormone-sensitive prostate cancer cells. Endocrinology. 2001;142:2419–2426.
Montgomery E, Goggins M, Zhou S, et al. Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects. Am J Pathol. 2001;158:537–544.
Shin KH, Park JG. Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1. Eur J Cancer. 2000;36:925–931.
Wang D, Zhang WM. Study on carcinogenesis and abnormal methylation of DNA. Journal of Sanming College 2002;19:40–44.
Genereux DP, Miner BE, Bergstrom CT, et al. A population-epigenetic model to infer site-specific methylation rates from double-stranded DNA methylation patterns. Proc Natl Acad Sci USA. 2005;102:5802–5807.
Herman J G, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA. 1998;95:6870–6875.
Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248–5257.
Wang D, XU Y, Geng X, et al. Analysis of inactivation of hMLH1 by promoter hypermethylation and microsatellite instability in gastric carcinogenesis. Chin J Clin Oncol 2006;2:102–109.
Becouarn Y, Rullier A, Gorry P, et al. Value of microsatellite instability typing in detecting hereditary non-polyposis colorectal cancer. A prospective multicentric study by the Association Aquitaine Gastro. Gastroenterol Clin Biol. 2005;29:667–675.
Iino H, Jass JR, Simms LA. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol. 1999;52:5–9.
Li H, Xu D, Toh BH, et al. TGF-beta and cancer: Is Smad3 a repressor of hTERT gene? Cell Res. 2006;16:169–73.
Alvi AJ, Rader JS, Broggini M, et al. Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFßR2) in sporadic ovarian cancer. Mol Pathol. 2001;54:240–243.
Deckers M, Van Dinther M, Buijs J, et al. The tumor suppressor Smad4 is required for transforming growth factor beta -induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 2006;66:2202–2209.